| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.023 | 0.6 |